Skip to content

Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-520840-14-00
Acronym
BIA-28-6156-113
Enrollment
32
Registered
2025-04-08
Start date
2025-04-29
Completion date
2025-07-24
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

None listed

Sponsors

Bial Portela & Ca S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026